Safe Orthopaedics SA (EPA:ALSAF)

France · Delayed Price · Currency is EUR

0.6400

0.00 (0.00%)

At close: Oct 16, 2026

Market Cap	127.51K -41.8%
Revenue (ttm)	5.36M -3.0%
Net Income	-4.67M
EPS	-23.46
Shares Out	199.24K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.6400
Day's Range	n/a
52-Week Range	0.5400 - 2.6000
Beta	-0.78
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 22, 2026

About Safe Orthopaedics

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use sterile implants and instrumentation for spinal surgery in France. It provides SteriSpine PS, for posture vixation; SteriSpine VA, a vertebral fracture solution; and SteriSpine CC/LC, an interbody fusion solution, including Walnut, Cedar, and Elm interbody cages. The company was founded in 2010 and is headquartered in Fleurieux-sur-l'Arbresle, France [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2010

Employees 87

Stock Exchange Euronext Paris

Ticker Symbol ALSAF

Full Company Profile

Financial Performance

In 2025, Safe Orthopaedics's revenue was 5.36 million, an increase of 6.41% compared to the previous year's 5.04 million. Losses were -4.67 million, -99.76% less than in 2024.

Financial Statements